|
|
| | Benzamide, 2-(6-azaspiro[2.5]oct-6-yl)-4-[[(2-hydroxyethyl)sulfonyl]amino]-N-[6-[(2R)-2-methyl-4-morpholinyl]-2-pyridinyl]- Basic information |
| | Benzamide, 2-(6-azaspiro[2.5]oct-6-yl)-4-[[(2-hydroxyethyl)sulfonyl]amino]-N-[6-[(2R)-2-methyl-4-morpholinyl]-2-pyridinyl]- Chemical Properties |
| density | 1.40±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | pka | 5.49±0.10(Predicted) | | form | Solid | | color | White to light yellow | | InChIKey | IUDCFCQNVQWCCI-LJQANCHMSA-N | | SMILES | C(NC1=NC(N2CCO[C@H](C)C2)=CC=C1)(=O)C1=CC=C(NS(CCO)(=O)=O)C=C1N1CCC2(CC2)CC1 |
| | Benzamide, 2-(6-azaspiro[2.5]oct-6-yl)-4-[[(2-hydroxyethyl)sulfonyl]amino]-N-[6-[(2R)-2-methyl-4-morpholinyl]-2-pyridinyl]- Usage And Synthesis |
| Uses | AM-5308 is a potent kinesin KIF18A inhibitor (WO2021211549A1, C13)[1]. | | Biological Activity | AM-5308 is a potent kinesin KIF18A inhibitor (WO2021211549A1, C13)[1]. | | References | [1]. Marc Noel PAYTON, et al. Kif18a inhibitors for treatment of neoplastic diseases. WO2021211549A1. |
| | Benzamide, 2-(6-azaspiro[2.5]oct-6-yl)-4-[[(2-hydroxyethyl)sulfonyl]amino]-N-[6-[(2R)-2-methyl-4-morpholinyl]-2-pyridinyl]- Preparation Products And Raw materials |
|